Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiomyopathy, Dilated

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiomyopathy, Dilated in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichihara, S; McKenna, CJ; Yamada, Y; Yokota, M1
Gabbasov, ZA; Naumov, VG; Okur, FM; Popov, EG; Skvortsov, AA1

Other Studies

2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiomyopathy, Dilated

ArticleYear
Familial dilated cardiomyopathy.
    Circulation, 1999, Oct-26, Volume: 100, Issue:17

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Cardiomyopathy, Dilated; Humans; Mutation, Missense; Phospholipases A; Platelet Activating Factor

1999
[New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy].
    Terapevticheskii arkhiv, 1989, Volume: 61, Issue:2

    Topics: Adenosine Diphosphate; Adolescent; Adult; Cardiomyopathy, Dilated; Culture Media; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Function Tests; Stimulation, Chemical

1989